Back

AchieveCE

  • Papillomavirus Infections
  • Patient Preference
  • Uterine Cervical Neoplasms
  • Vaccination

Cervical Cancer Screening: Primary HPV Testing, Self-Collection, and Clinical Follow-Up

Between January and April 2026, U.S. cervical cancer screening guidance changed in ways that affect test selection, specimen collection, screening itervals, and follow-up. HRSA/WPSI added patient-collected hrHPV testing as an option for average-risk patients aged 30 to 65 years, while ACOG identified clinician-collected primary hrHPV testing every five years as the preferred strategy and qualified patient collection based on patient preference and established documentation, notification, and follow-up processes. This course addresses the resulting knowledge and practice gap by helping clinicians and supporting teams determine eligibility, select a guideline-concordant strategy and interval, verify appropriate assay-device-specimen-setting configurations, apply genotype-informed follow-up, and close the loop after abnormal results. Cervical cancer treatment and comprehensive HPV vaccination education are outside the scope of this course.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AMA PRA Category 1 Credit™Up to 3 credits

MOC types

No MOC

FDA REMS

No

Qualifies for MIPS

No

Target Specialties

No specific specialties targeted.

Pricing

Paid

This provider typically $19–30

See fees on achievece.com

Listed by the provider

  • Article / monograph / reference
  • Credit · Up to 3 credits
  • Paid · this provider typically $19–30
  • Released
    Sep 11, 2026
  • Last day to claim credit
    Sep 12, 2029 3 years left